120 related articles for article (PubMed ID: 23574351)
1. A family with fragile X syndrome, Duchenne muscular dystrophy and ichthyosis transmitted by an asymptomatic carrier.
Todorova A; Litvinenko I; Todorov T; Tincheva R; Avdjieva D; Tincheva S; Mitev V
Clin Genet; 2014 Mar; 85(3):286-9. PubMed ID: 23574351
[TBL] [Abstract][Full Text] [Related]
2. Xp22.3 interstitial deletion: a recognizable chromosomal abnormality encompassing VCX3A and STS genes in a patient with X-linked ichthyosis and mental retardation.
Ben Khelifa H; Soyah N; Ben-Abdallah-Bouhjar I; Gritly R; Sanlaville D; Elghezal H; Saad A; Mougou-Zerelli S
Gene; 2013 Sep; 527(2):578-83. PubMed ID: 23791652
[TBL] [Abstract][Full Text] [Related]
3. Co-Occurrence of Fragile X Syndrome with a Second Genetic Condition: Three Independent Cases of Double Diagnosis.
Tabolacci E; Pomponi MG; Remondini L; Pietrobono R; Orteschi D; Nobile V; Pucci C; Musto E; Pane M; Mercuri EM; Neri G; Genuardi M; Chiurazzi P; Zollino M
Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946857
[TBL] [Abstract][Full Text] [Related]
4. The Fragile X premutation: new insights and clinical consequences.
Van Esch H
Eur J Med Genet; 2006; 49(1):1-8. PubMed ID: 16473304
[TBL] [Abstract][Full Text] [Related]
5. [Genetic analysis for a child with comorbid X-linked ichthyosis and Duchenne muscular dystrophy].
Zhang C; Hao S; Hui L; Feng X; Chen X; Wang X; Zheng L; Liu F; Zhou B; Zhang Q
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Aug; 39(8):877-880. PubMed ID: 35929940
[TBL] [Abstract][Full Text] [Related]
6. Unraveling unusual X-chromosome patterns during fragile-X syndrome genetic testing.
Esposito G; Tremolaterra MR; Savarese M; Spiniello M; Patrizio MP; Lombardo B; Pastore L; Salvatore F; Carsana A
Clin Chim Acta; 2018 Jan; 476():167-172. PubMed ID: 29170104
[TBL] [Abstract][Full Text] [Related]
7. CGG-repeat dynamics and
Zhou Y; Kumari D; Sciascia N; Usdin K
Mol Autism; 2016; 7():42. PubMed ID: 27713816
[TBL] [Abstract][Full Text] [Related]
8. A deletion of 1.6 kb proximal to the CGG repeat of the FMR1 gene causes the clinical phenotype of the fragile X syndrome.
Meijer H; de Graaff E; Merckx DM; Jongbloed RJ; de Die-Smulders CE; Engelen JJ; Fryns JP; Curfs PM; Oostra BA
Hum Mol Genet; 1994 Apr; 3(4):615-20. PubMed ID: 8069307
[TBL] [Abstract][Full Text] [Related]
9. [FMR1 PREMUTATION CARRIERS - ARE THEY REALLY ASYMPTOMATIC?].
Elizur S; Berkenstadt M; Ries-Levavi L; Gruber N; Pinhas-Hamiel O; Hassin-Baer S; Raas-Rothschild A; Raanani H; Cukierman-Yaffe T; Orvieto R; Cohen Y; Gabis L
Harefuah; 2018 Apr; 157(4):241-244. PubMed ID: 29688643
[TBL] [Abstract][Full Text] [Related]
10. Molecular diagnosis of fragile X syndrome using methylation sensitive techniques in a cohort of patients with intellectual disability.
Chaudhary AG; Hussein IR; Abuzenadah A; Gari M; Bassiouni R; Sogaty S; Lary S; Al-Quaiti M; Al Balwi M; Al Qahtani M
Pediatr Neurol; 2014 Apr; 50(4):368-76. PubMed ID: 24630283
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis.
Cronister A; Teicher J; Rohlfs EM; Donnenfeld A; Hallam S
Obstet Gynecol; 2008 Mar; 111(3):596-601. PubMed ID: 18310361
[TBL] [Abstract][Full Text] [Related]
12. FMR1 CGG repeat lengths mediate different regulation of reporter gene expression in comparative transient and locus specific integration assays.
Sølvsten C; Nielsen AL
Gene; 2011 Oct; 486(1-2):15-22. PubMed ID: 21767618
[TBL] [Abstract][Full Text] [Related]
13. Molecular predictors of cognitive involvement in female carriers of fragile X syndrome.
Taylor AK; Safanda JF; Fall MZ; Quince C; Lang KA; Hull CE; Carpenter I; Staley LW; Hagerman RJ
JAMA; 1994 Feb; 271(7):507-14. PubMed ID: 8301764
[TBL] [Abstract][Full Text] [Related]
14. FMR1 CGG repeat expansion mutation detection and linked haplotype analysis for reliable and accurate preimplantation genetic diagnosis of fragile X syndrome.
Rajan-Babu IS; Lian M; Cheah FSH; Chen M; Tan ASC; Prasath EB; Loh SF; Chong SS
Expert Rev Mol Med; 2017 Jul; 19():e10. PubMed ID: 28720156
[TBL] [Abstract][Full Text] [Related]
15. An assessment of screening strategies for fragile X syndrome in the UK.
Pembrey ME; Barnicoat AJ; Carmichael B; Bobrow M; Turner G
Health Technol Assess; 2001; 5(7):1-95. PubMed ID: 11262423
[TBL] [Abstract][Full Text] [Related]
16. Identification of fragile X pre-mutation carriers in the Chinese obstetric population using a robust FMR1 polymerase chain reaction assay: implications for screening and prenatal diagnosis.
Cheng YK; Lin CS; Kwok YK; Chan YM; Lau TK; Leung TY; Choy KW
Hong Kong Med J; 2017 Apr; 23(2):110-6. PubMed ID: 28253484
[TBL] [Abstract][Full Text] [Related]
17. [Genetic analysis and prenatal diagnosis of Duchenne or Becker muscular dystrophy].
Zhao W; Jiang N; Li S; Li JS; Miao Y; Liang SY; Yu DY
Zhonghua Fu Chan Ke Za Zhi; 2019 Apr; 54(4):226-231. PubMed ID: 31006187
[No Abstract] [Full Text] [Related]
18. FMR1 gene deletion/reversion: a pitfall of fragile X carrier testing.
Gasteiger M; Grasbon-Frodl E; Neitzel B; Kooy F; Holinski-Feder E
Genet Test; 2003; 7(4):303-8. PubMed ID: 15000806
[TBL] [Abstract][Full Text] [Related]
19. A homogeneous assay for analysis of FMR1 promoter methylation in patients with fragile X syndrome.
Dahl C; Grønskov K; Larsen LA; Guldberg P; Brøndum-Nielsen K
Clin Chem; 2007 Apr; 53(4):790-3. PubMed ID: 17259243
[TBL] [Abstract][Full Text] [Related]
20. Methylation mosaicism of 5'-(CGG)(n)-3' repeats in fragile X, premutation and normal individuals.
Genç B; Müller-Hartmann H; Zeschnigk M; Deissler H; Schmitz B; Majewski F; von Gontard A; Doerfler W
Nucleic Acids Res; 2000 May; 28(10):2141-52. PubMed ID: 10773084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
